Full name
PCS EUROPE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of medicines and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical substances
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.69.Z - Wholesale of other machinery and equipment
49.41.Z - Freight transport by road
52.10.B - Warehousing and storage of other goods
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
82.92.Z - Packaging activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -121,3 | -154,9 | 59,1 | 138,1 |
Gross profit (loss) | -104,1 | -178,5 | 59,5 | 133,3 |
EBITDA | -97,6 | -180,1 | 61 | 133,9 |
Short time liabilities | 235,2 | 423,4 | 591,7 | 39,7 |
Other operating costs | 9,1 | 28,4 | 6,6 | -76,6 |
Equity capital | -112,1 | -290,6 | -231,1 | 20,5 |
Operating profit (EBIT) | -102,9 | -182,9 | 61 | 133,4 |
Assets | 123,1 | 194,3 | 457,1 | 135,2 |
Net profit (loss) | -104,1 | -178,5 | 59,5 | 133,3 |
Cash | 0,7 | 0,3 | 2 | 648 |
Net income from sale | 440 | 414,7 | 615,7 | 48,5 |
Liabilities and provisions for liabilities | 235,2 | 484,9 | 688,2 | 41,9 |
Working assets | 123,1 | 194,3 | 457,1 | 135,2 |
Other income costs | 27,5 | 0,4 | 8,6 | 2175,4 |
Depreciation | 5,3 | 2,8 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 92,8 | 61,4 | -25,7 | -87,1 |
Equity capital to total assets | -91,1 | -149,6 | -50,6 | 99 |
Gross profit margin | -23,6 | -43,1 | 9,7 | 52,8 |
EBITDA Margin | -22,2 | -43,4 | 9,9 | 53,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 195 | 373 | 351 | -22 |
Current financial liquidity indicator | 0.5234038233757019 | 0.45891714096069336 | 0.7724998593330383 | 0,3 |
Net dept to EBITDA | -0.3274069130420685 | -0.33994999527931213 | 1.5483797788619995 | 1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane